AKT1 and neoplasm: In retinoblastoma (RB) mice, treatment with lupeol [46,47] not only inhibits skin cancer by inhibiting PI3K, Akt phosphorylation, nuclear factor kappa-B (NF-κB)/p65, and IKKα activity but also inhibits the proliferation of ocular cancer cells and suppresses tumor development in vivo.